COUNTRY OF ORIGIN — MULTINATIONAL

SORT date author clear filters


FILTER RECORDS BY


Malaria Commission of the Health Organisation (1925)
Report on its tour of investigation in certain European countries in 1924. Geneva: League of Nations. C.H. 273.

View

Malaria Commission (1937)
The treatment of Malaria: Study of synthetic drugs, as compared with Quinine, in the therapeutics and prophylaxis of Malaria. Bulletin of the Health Organisation, Vol VI, no. 6.

View

Pollock TM, Bell JA, Hill AB, Cockburn WC, Cvjetanović B, Evans DG, Kostrzewski J, Schofield FD (1966)
Trials of Prophylactic agents for the control of communicable diseases: a guide to their organization and evaluation‎. Geneva: World Health Organization.

View

Garvey WD, Lin N, Nelson CE (1970)
Communication in the physical and social sciences: the process of disseminating and assimilating information differ in these two groups of science. Science 170:1166-1173.

View

International Anticoagulant Review Group (1970)
Collaborative analysis of long-term anti-coagulant administration after acute myocardial infarction. Lancet 1:203-209.

View

Storey J, Rossi-Espagnet A, Mandel SPH, Matsushima T, Lietaert P, Thomas D, Brøgger S, Duby C, Gramiccia G (1973)
Sulfalene with pyrimethamine and chloroquine with pyrimethamine in single-dose treatment of Plasmodium falciparum infections. Bulletin of the World Health Organisation 49: 275-282.

View

Dudley HAF (1978)
Surgical research: master or servant. The American Journal of Surgery 135:458-460.

View

ISIS-1 (first International Study of Infarct Survival) Collaborative Group (1986)
Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. First International Study of Infarct Survival Collaborative Group. Lancet 2:57-66.

View

World Health Organisation European Collaborative Group (1986)
European collaborative trial of multifactorial prevention of coronary heart disease: final report on the 6-year results. Lancet 1:869-72.

View

Yusuf S, Simon R, Ellenberg SS (1987)
Proceedings of the workshop on methodologic issues in overviews of randomized clinical trials, May 1986. Statistics in Medicine 6:217-409.

View

Ad Hoc Working Group for Critical Appraisal of the Medical Literature (1987)
A proposal for more informative abstracts of clinical articles. Annals of Internal Medicine 106:598-604.

View

MacMahon S, Collins R, Peto R, Koster RW, Yusuf S (1988)
Effects of prophylactic lidocaine in suspected acute myocardial infarction. An overview of results from the randomized, controlled trials. JAMA 260:1910-6.

View

Chalmers I, ed (1988)
The Oxford Database of Perinatal Trials. Oxford: Oxford University Press.

View

Chalmers TC (1988)
Data analysis for clinical medicine: the quantitative approach to patient care in gastroenterology. Rome: International University Press.

View

Early Breast Cancer Trialists' Collaborative Group (1988)
Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women. New England Journal of Medicine 319:1681-92.

View

Antiplatelet Trialists' Collaboration (1988)
Secondary prevention of vascular disease by prolonged anti-platelet treatment. BMJ 296:320-331.

View

Dickersin K (1988)
Report from the panel on the case for registers of clinical trials at the eighth annual meeting of the Society for Clinical Trials. Control Clinical Trials 9:76-81.

View

ISIS-2 (second International Study of Infarct Survival) Collaborative Group (1988)
Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17 187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 332:349–360.

View

Chalmers I, Enkin M, Keirse MJNC (1989)
Effective care in pregnancy and childbirth. Oxford: Oxford University Press.

View

Early Breast Cancer Trialists' Collaborative Group (1990)
Treatment of early breast cancer. Vol 1. Worldwide evidence, 1985-1990. Oxford: Oxford University Press.

View

Advanced Ovarian Cancer Trialists Group (1991)
Chemotherapy in advanced ovarian cancer: an overview of randomised clinical trials. BMJ 303:884-893.

View

Easterbrook PJ, Berlin JA, Gopalan R, Matthews DR (1991)
Publication bias in clinical research. Lancet 37:867-72.

View

ACP Journal Club (1991)
Supplement to Annals of Internal Medicine. Philadelphia: American College of Physicians, Volume 114, Supplement 1.

View

Sinclair JC, Bracken MB (1992)
Effective care of the newborn infant. Oxford: Oxford University Press.

View

Cochrane Pregnancy and Childbirth Group (1994)
The Cochrane Pregnancy and Childbirth Database. Oxford: Update Software

View

Standards of Reporting Trials Group (1994)
A proposal for structured reporting of randomized controlled trials. JAMA 272:1926-31.

View

Cholesterol Treatment Trialists’ (CTT) Collaboration (1995)
Protocol for a prospective collaborative overview of all current and planned randomized trials of cholesterol treatment regimens. American Journal of Cardiology 75:1130-1134.

View

The CONSORT Group (1996)
Improving the quality of reporting of randomized controlled trials. The CONSORT Statement. JAMA 276:637-639.

View

Lee WL, Bausell RB, Berman BM (2001)
The growth of health-related meta-analyses published from 1980 to 2000. Evaluation and the Health Professions 24: 327-335.

View

Wagner AK, Soumerai SB, Zhang F, Ross-Degnan D (2002)
Segmented regression analysis of interrupted time series studies in medication use research. Journal of Clinical Pharmacy and Therapeutics 27:299–309.

View

Atkins D, Eccles M, Flottorp S, Guyatt GH, Henry D, Hill S, Liberati A, O'Connell D, Oxman AD, Phillips B, Schünemann H, Edejer TT, Vist GE, Williams JW and The GRADE Working Group (2004)
Systems for grading the quality of evidence and the strength of recommendations I: Critical appraisal of existing approaches The GRADE Working Group. BMC Health Services Research 2004 4:38 doi.org/10.1186/1472-6963-4-38.

View

Montori VM, Devereaux PJ, Adhikari NK, Burns KE, Eggert CH, Briel M, Lacchetti C, Leung TW, Darling E, Bryant DM, Bucher HC, Schunemann HJ, Meade MO, Cook DJ, Erwin PJ, Sood A, Sood R, Lo B, Thompson CA, Zhou Q, Mills E, Guyatt GH (2005)
Randomized trials stopped early for benefit: a systematic review. JAMA 294:2203-2209.

View

Perel P, Roberts I, Sena E, Wheble P, Briscoe C, Sandercock S, Macleod M,  Mignini LE, Jayaram P, Khan KS (2007)
Comparison of treatment effects between animal experiments and clinical trials: systematic review. BMJ 334:197-200.

View

Moher D, Tetzlaff J, Tricco AC, Sampson M, Altman DG (2007)
Epidemiology and reporting characteristics of systematic reviews. PLoS Medicine 4(3):e78.

View

Bastian H, Glasziou P, Chalmers I (2010)
Seventy-five trials and eleven systematic reviews a day: how will we ever keep up? PLoS Medicine 7:e1000326.

View

Bassler D, Briel M, Montori VM, Lane M, Glasziou P, Zhou Q, Heels-Ansdell D, Walter SD, Guyatt GH; STOPIT-2 Study Group (2010)
Stopping randomized trials early for benefit and estimation of treatment effects: systematic review and meta-regression analysis. JAMA. 303:1180-7.

View

Sena ES, van der Worp HB, Bath PMW, Howells DW, Macleod MR (2010)
Publication bias in reports of animal Stroke studies leads to major overstatement of efficacy. PLoS Biol 8(3): e1000344. doi:10.1371/journal.pbio.1000344

View

Montedori A, Cherubini A, Bonacini MI, Casazza G, Luchetta ML, Duca P, Cozzolino F, Abraha I (2011)
Modified versus standard intention-to-treat reporting: Are there differences in methodological quality, sponsorship, and findings in randomised trials? A cross-sectional study. Trials 12:58.

View

Savović J, Jones HE, Altman DG, Harris RJ, Jüni P, Pildal J, Als-Nielsen B, Balk EM, Gluud C, Gluud LL, Ioannidis JPA, Schulz KF, Beynon R, Welton NJ, Wood L, Moher D, Deeks JJ, Sterne JAC (2012)
Influence of reported study design characteristics on intervention effect estimates from randomized controlled trials. Annals of Internal Medicine 157:429-438.

View

Tsilidis KK, Panagiotou OA, Sena ES, Aretouli E, Evangelou E, Howells DW, Salman RA, Macleod MR, Ioannidis JPA (2013)
Evaluation of excess significance bias in animal studies of neurological diseases. PLoS Biol 11: e1001609. doi:10.1371/journal.pbio.1001609.

View

Fretheim A, Zhang F, Ross-Degnan D, Oxman AD, Cheyne H, Foy R, Goodacre S, Herrin J, Kerse N, McKinlay RJ, Wright A, Soumerai SB (2014)
A reanalysis of cluster randomized trials showed interrupted time-series studies were valuable in health system evaluation. Journal of Clinical Epidemiology 68:324-33.

View

Jefferson T, Jones MA, Doshi P, Del Mar CB, Hama R, Thompson MJ, Spencer EA, Onakpoya I, Mahtani KR, Nunan D, Howick J, Heneghan CJ (2014)
Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. Cochrane Database of Systematic Reviews 2014, Issue 4. Art. No.: CD008965. DOI:10.1002/14651858.CD008965.pub4.

View

Abraha I, Cherubini A, Cozzolino F, De Florio R, Luchetta ML, Rimland JM, Folletti I, Marchesi M, Germani A, Orso M, Eusebi P, Montedori A (2015)
Deviation from intention to treat analysis in randomised trials and treatment effect estimates: meta-epidemiological study. BMJ 2015;350:h2445.

View

Page MJ, Shamseer L, Altman DG, Tetzlaff J, Sampson M, Tricco AC, Catalá-López F, Li L, Reid EK, Sarkis-Onofre R, Moher D (2016)
Epidemiology and reporting characteristics of systematic reviews of biomedical research: a cross-sectional study. PLoS Medicine 13(5):e1002028.

View

Hooijmans CR, de Vries RBM, Ritskes-Hoitinga M, Rovers MM, Leeflang MM, IntHout J, Wever KE, Hooft L, de Beer H, Kuijpers T, Macleod MR, Sena ES, ter Riet G, Morgan RL, Thayer KA, Rooney AA, Guyatt GH, Schünemann HJ, Langendam MW, GRADE Working Group (2018)
Facilitating healthcare decisions by assessing the certainty in the evidence from preclinical animal studies. PLoS One 13:e0187271. doi: 10.1371/journal.pone.0187271.

View

Scherer RW, Meerpohl JJ, Pfeifer N, Schmucker C, Schwarzer G, von Elm E (2018)
Full publication of results initially presented in abstracts. Cochrane Database of Systematic Reviews; (11): MR000005.

View

Gurevitch J, Koricheva J, Nakagawa S, Stewart G (2018)
Meta-analysis and the science of research synthesis. Nature 555:175-182. 10.1038/nature25753.

View

Vollert J, Schenker E, Macleod M, Bespalov A, Wuerbel H, Michel M, Dirnagl U, Potschka H, Waldron AM, Wever K, Steckler T, van de Casteele T, Altevogt B, Sil A, Rice ASC, The EQIPD WP3 study group members (2020)
Systematic review of guidelines for internal validity in the design, conduct and analysis of preclinical biomedical experiments involving laboratory animals. BMJ Open Science 4:e100046. doi:10.1136/bmjos-2019-100046

View

Percie du Sert N, Hurst V, Ahluwalia A, Alam S, Avey MT, Baker M, Browne WJ, Clark A, Cuthill IC, Dirnagl U, Emerson M, Garner P, Holgate ST, Howells DW, Karp NA, Lazic SE, Lidster K, MacCallum CJ, Macleod M, Pearl EJ, Petersen OH, Rawle F, Reynolds P, Rooney K, Sena ES, Silberberg SD, Steckler T, Würbel H (2020)
The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research. PLoS Biol 18(7): e3000410. https://doi.org/10.1371/journal.

View

Pérez-Gaxiola G, Verdugo-Paiva F, Rada G, Flórez ID (2021)
Assessment of Duplicate Evidence in Systematic Reviews of Imaging Findings of Children With COVID-19. JAMA Network Open 4(1):e2032690.

View

D'Aquila RT, Hughes MD, Johnson VA, Fischl MA, Sommadossi JP, Liou SH, Timpone J, Myers M, Basgoz N, Niu M, Hirsch MS (2021)
Nevirapine, zidovudine, and didanosine compared with zidovudine and didanosine in patients with HIV-1 infection. A randomized, double- blind, placebo-controlled trial. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group Protocol 241 Investigators. Annals of Internal Medicine 124:1019-1030.

View

Dirven H, Vist GE, Bandhakavi S, Mehta J, Fitch SE, Pound P, Ram R, Kincaid B, Leenaars CHC, Chen M, Wright RA, Tsaioun K (2021)
Performance of preclinical models in predicting drug-induced liver injury in humans: a systematic review. Sci Rep 11:6403. doi: 10.1038/s41598-021-85708-2.

View

Nothing found, please try resetting your search filters